SWOG clinical trial number
SWOG-8294 (INT-0011) (EST-1180)
Evaluation of Adjuvant Therapy and Biological Parameters in Node Negative Operable Female Breast Cancer
Closed
Phase
Published
Abbreviated Title
Evaluation of Adjuvant Therapy and Biological Parameters in Node Negative Operable Female Breast Cancer
Activated
05/15/1986
Closed
05/15/1988
Publication Information Expand/Collapse
1995
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
1992
Prognostic significance of S-Phase fraction in good risk node-negative breast cancer patients.
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
1990
Adjuvant therapy in node-negative breast cancer. It is necessary for all patients. An Intergroup study.